Surfactant Protein D Levels in GCF Before and After MINST in Periodontitis
Recruiting
N/A
Interventional Study
Periodontitis
Periodontitis Stage II
Periodontitis Stage III
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 18 (estimated)
- Sponsor
- Cairo University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will evaluate changes in Surfactant Protein D (SP-D) levels in gingival crevicular fluid (GCF) of patients with periodontitis before and after minimally invasive non-surgical periodontal therapy (MINST).
Participants diagnosed with stage II or III periodontitis will receive minimally invasive non-surgical periodontal treatment. GCF samples will be collected at baseline and 6 months aft…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male and female participants aged 18 years or older.
* Diagnosis of periodontitis, classified as stage II or stage III according to the 2018 classification system.
* Presence of at least one tooth with probing pocket depth (PPD) of 5 mm or more, clinical attachment loss (CAL),…
Contacts